DTC Public Health Slant: A Winning Formula With FDA Commissioner Hamburg
This article was originally published in RPM Report
Executive Summary
FDA Commissioner Margaret Hamburg is not taking the easy way out when she discusses DTC, even in front of Congressional critics of the practice. She does not treat DTC as primarily a regulatory problem for the agency; instead she likes to focus on the public health potential of DTC.